Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation TCT 2022

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

Presenter: Alexander R. Tamm

September 18, 2022

The Dedicated JenaValve TAVR System for AI: Early EU and US Experiences

Presentation TCT 2022

The Dedicated JenaValve TAVR System for AI: Early EU Experience

Presenter: Alexander Tamm

September 18, 2022

Presentation TCT 2022

TCT 678: Jenavalve Trilogy TAVR for severe aortic regurgitation in patient with osteogenesis imperfecta, ascending aneurysm, and severe thoracic tortuosity

Presenter: Stanley Chetcuti

September 17, 2022

Presentation TCT 2022

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

Presenter: Lauren Ranard

September 17, 2022

Presentation TVT 2022

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

Presenter: Jubin Joseph

June 09, 2022

Presentation TVT 2022

JenaValve to treat a degenerative regurgitant aortic valve following previous Ross procedure with no annular calcium.

Presenter: Jubin Joseph

June 09, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Presenter: Matti Adam

June 08, 2022

Presentation TVT 2022

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

Presenter: Vinod Thourani

June 08, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

Partner Content

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

October 10, 2022

Video

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

October 6, 2022

Video

Aortic Regurgitation in 2022- Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

July 13, 2022

Advertisement

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

The Dedicated JenaValve TAVR System for AI: Early EU Experience

TCT 678: Jenavalve Trilogy TAVR for severe aortic regurgitation in patient with osteogenesis imperfecta, ascending aneurysm, and severe thoracic tortuosity

TCT 638: Sequential transcatheter treatment of severe mitral and aortic regurgitation with MitraClip and JenaValve Trilogy in a patient with cardiogenic shock

TAVR with JenaValve system following degenerative aortic valve repair with severe aortic regurgitation.

JenaValve to treat a degenerative regurgitant aortic valve following previous Ross procedure with no annular calcium.

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Rapidly Evolving EU Experiences With the JenaValve for AR and AS

Updates on the Dedicated JenaValve TAVR System and the ALIGN AR Trial

TCTMD’s Top 10 Most Popular Stories for May 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

TAVR for Aortic Regurgitation: The Completion of the ALIGN-AR Study and the Future Paradigm of AR Treatment

Aortic Regurgitation in 2022- Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content